Keasling Biomanufacturing ApS: Financial statements 2025
CVR: 43607774
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Keasling Biomanufacturing ApS (CVR 43607774) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -9,942 and a net result of DKK -11,228 compared with DKK -23,957 the year before. Equity in the 2025 report amounted to DKK 35,914. The solvency ratio was 69.5%.
- Gross Profit
- DKK -9,942
- Profit/Loss
- DKK -11,228
- Equity
- DKK 35,914
- Total Assets
- DKK 51,694
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -10 t. | -11 t. | 36 t. | 0 |
| 2024 | - | -25 t. | -24 t. | 47 t. | 0 |
Official annual report
How creditworthy is Keasling Biomanufacturing ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Keasling Biomanufacturing ApS has published its annual report for 2024. Gross profit came to DKK -25,058, and the net result was DKK -23,957.
About Keasling Biomanufacturing ApS
Keasling Biomanufacturing ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jay D Keasling. The company is owned by The Jay D. Keasling Trust. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,942 and a net result of DKK -11,228 compared with DKK -23,957 the year before. Equity in the 2025 report amounted to DKK 35,914.